EDC-1

N/A

Report date: 2024/11/19 16:57:51

Base Information

Drug NameEDC-1
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Non-cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionSodium/potassium-transporting ATPase alpha-1 chain modulatorsSodium/potassium-transporting ATPase subunit gamma modulatorsTyrosine-protein kinase FYN modulators +[4] 
TargetsSodium/potassium-transporting ATPase alpha-1 chainFXYD domain-containing ion transport regulator 2Tyrosine-protein kinase FYN +[4] 
Therapy Area/IndicationsKidney NeoplasmsPancreatic NeoplasmsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWisconsin Alumni Research Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentrose LLC
Active IndicationsN/A
Inactive IndicationsKidney NeoplasmsPancreatic NeoplasmsLymphoma

Other Information

ATC CodeN/A
Related LinksN/A